Gina Mazzariello, Chief Legal Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 30,000 shares at $18.32 ($539K) on 2026-07-09, disclosed to the SEC on 2026-07-13.
Scheduled sale ($539k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.32 | 15,000 | $275K | 51.0% |
| 2 | $17.61 | 15,000 | $264K | 49.0% |
| Total | $17.96 avg | 30,000 | $539K | 100% |
| Filing → |
| AMLX | SELL | 2026-02-25 | $48K | — | Filing → |
| AMLX | SELL | 2026-02-04 | $51K | — | Filing → |
| AMLX | SELL | 2025-10-02 | $257K | — | Filing → |